BIOCRYST PHARMACEUTICALS INC [BCRX] has reported fiscal Q1 profit of $53.33 million.
On a per-share basis, the DE based company said its diluted earnings are $0.28.
The Biological Products, Except Diagnostic Substances firm posted revenue of $68.80 million in this period.
Also Read: